Teal Omics

Teal Rise is a private, early-stage diagnostics company founded in 2021, commercializing breakthrough research from Stanford University on proteomic organ aging clocks. Its core platform analyzes over 11,000 plasma proteins to assess the biological age of 11+ individual organ systems, providing insights into disease risk, intervention impact, and causal biology. The company is positioned to serve research and pharmaceutical partners, with a clear path toward developing novel clinical diagnostics for age-related and chronic diseases. It is currently in a pre-revenue, platform-validation stage.

Proteomics-based platform analyzing ~11,000 plasma proteins to estimate biological age of 11+ organ systems. Integrates a massive proteogenomic dataset (100K+ samples) with Mendelian randomization for causal inference.

Teal competes in the broad multi-omics and aging biomarker space. Direct competitors include other proteomics startups (e.g., SomaLogic, Olink) and biological age test companies (e.g., Elysium Health, InsideTracker), but Teal's unique focus on organ-specific proteomic clocks from a single blood test provides a differentiated offering. Long-term competition may come from large diagnostic labs developing similar panels.